MeVis Medical Solutions AG (M3V.DE)
EUR 26.0
(0.78%)
EUR 26.0
(0.78%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.12 Million EUR | -35.13% |
| 2022 | 7.96 Million EUR | 48.34% |
| 2021 | 5.37 Million EUR | -10.02% |
| 2020 | 5.97 Million EUR | -29.07% |
| 2019 | 8.41 Million EUR | 0.05% |
| 2018 | 8.02 Million EUR | -0.53% |
| 2017 | 7.85 Million EUR | 29.18% |
| 2016 | 6.31 Million EUR | -8.09% |
| 2015 | 6.76 Million EUR | 4.0% |
| 2014 | 6.35 Million EUR | 11.9% |
| 2013 | 5.9 Million EUR | 7.08% |
| 2012 | 5.62 Million EUR | 63.92% |
| 2011 | 3.53 Million EUR | -12.45% |
| 2010 | 3.97 Million EUR | -20.38% |
| 2009 | 5 Million EUR | 21.51% |
| 2008 | 4.11 Million EUR | 286.04% |
| 2007 | 1.06 Million EUR | -78.91% |
| 2006 | 5.06 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.17 Million EUR | 0.0% |
| 2024 Q1 | 1.17 Million EUR | -4.89% |
| 2023 Q1 | 1.24 Million EUR | -28.14% |
| 2023 FY | - EUR | -35.13% |
| 2023 Q4 | 1.23 Million EUR | 0.06% |
| 2023 Q3 | 1.23 Million EUR | -0.63% |
| 2023 Q2 | 1.24 Million EUR | 0.0% |
| 2022 Q3 | 1.73 Million EUR | -42.58% |
| 2022 FY | - EUR | 48.34% |
| 2022 Q4 | 1.72 Million EUR | -0.47% |
| 2022 Q1 | 1.55 Million EUR | -19.88% |
| 2022 Q2 | 3.02 Million EUR | 94.3% |
| 2021 Q1 | 1.26 Million EUR | -55.92% |
| 2021 FY | - EUR | -10.02% |
| 2021 Q4 | 1.94 Million EUR | 46.31% |
| 2021 Q3 | 1.32 Million EUR | -58.03% |
| 2021 Q2 | 3.16 Million EUR | 150.68% |
| 2020 FY | - EUR | -29.07% |
| 2020 Q1 | 1.54 Million EUR | -42.33% |
| 2020 Q2 | 2.95 Million EUR | 91.48% |
| 2020 Q3 | 1.36 Million EUR | -53.76% |
| 2020 Q4 | 2.86 Million EUR | 109.7% |
| 2019 Q4 | 2.67 Million EUR | 45.56% |
| 2019 FY | - EUR | 0.05% |
| 2019 Q3 | 1.83 Million EUR | 3.67% |
| 2019 Q2 | 1.77 Million EUR | -16.96% |
| 2019 Q1 | 2.13 Million EUR | -9.95% |
| 2018 Q3 | 1.52 Million EUR | 7.33% |
| 2018 Q2 | 1.41 Million EUR | -21.74% |
| 2018 Q1 | 1.81 Million EUR | -22.6% |
| 2018 FY | - EUR | -0.53% |
| 2018 Q4 | 2.37 Million EUR | 55.78% |
| 2017 Q1 | 4.79 Million EUR | 132.12% |
| 2017 Q3 | 693 Thousand EUR | 16.08% |
| 2017 Q4 | 2.34 Million EUR | 237.81% |
| 2017 Q2 | 597 Thousand EUR | -87.56% |
| 2017 FY | - EUR | 29.18% |
| 2016 Q4 | 2.06 Million EUR | 32.42% |
| 2016 Q1 | 1.2 Million EUR | -53.87% |
| 2016 FY | - EUR | -8.09% |
| 2016 Q3 | 1.56 Million EUR | 99.11% |
| 2016 Q2 | 784 Thousand EUR | -35.15% |
| 2015 FY | - EUR | 4.0% |
| 2015 Q4 | 2.62 Million EUR | 41.68% |
| 2015 Q3 | 1.85 Million EUR | 47.18% |
| 2015 Q2 | 1.25 Million EUR | -16.53% |
| 2015 Q1 | 1.5 Million EUR | -37.01% |
| 2014 Q4 | 2.39 Million EUR | 50.38% |
| 2014 Q3 | 1.59 Million EUR | 33.17% |
| 2014 Q2 | 1.19 Million EUR | -13.29% |
| 2014 Q1 | 1.37 Million EUR | -33.48% |
| 2014 FY | - EUR | 11.9% |
| 2013 Q2 | 1.42 Million EUR | 21.56% |
| 2013 Q1 | 1.16 Million EUR | -8.6% |
| 2013 FY | - EUR | 7.08% |
| 2013 Q3 | 1.22 Million EUR | -13.86% |
| 2013 Q4 | 2.07 Million EUR | 69.12% |
| 2012 Q3 | 1.8 Million EUR | 22.74% |
| 2012 Q4 | 1.27 Million EUR | -29.26% |
| 2012 Q2 | 1.47 Million EUR | 611.59% |
| 2012 FY | - EUR | 63.92% |
| 2012 Q1 | 207 Thousand EUR | -88.1% |
| 2011 Q3 | 320 Thousand EUR | -73.83% |
| 2011 Q1 | 104 Thousand EUR | -94.58% |
| 2011 FY | - EUR | -12.45% |
| 2011 Q2 | 1.22 Million EUR | 1075.96% |
| 2011 Q4 | 1.74 Million EUR | 443.75% |
| 2010 Q1 | 1.8 Million EUR | 69.01% |
| 2010 Q2 | 918 Thousand EUR | -49.0% |
| 2010 Q3 | 1.04 Million EUR | 13.62% |
| 2010 FY | - EUR | -20.38% |
| 2010 Q4 | 1.91 Million EUR | 83.99% |
| 2009 Q4 | 1.06 Million EUR | -22.88% |
| 2009 Q2 | 759 Thousand EUR | 0.0% |
| 2009 FY | - EUR | 21.51% |
| 2009 Q3 | 1.38 Million EUR | 81.95% |
| 2008 Q3 | 1.05 Million EUR | 0.0% |
| 2008 FY | - EUR | 286.04% |
| 2007 FY | - EUR | -78.91% |
| 2006 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| DocCheck AG | 9.38 Million EUR | 45.328% |
| CompuGroup Medical SE & Co. KGaA | 215.84 Million EUR | 97.623% |
| Nexus AG | 53.43 Million EUR | 90.4% |